Cardiol Therapeutics Net Debt Growth & History (CRDL)

Cardiol Therapeutics's net debt was −$21.3M for fiscal 2025.

View full Cardiol Therapeutics company overview

Cardiol Therapeutics annual net debt history

Cardiol Therapeutics annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$21.3M$9.1M
20242024-12-31−$30.4M$4.3M
20232023-12-31−$34.8M$24.6M
20222022-12-31−$59.4M$24.4M
20212021-12-31−$83.8M−$69.9M
20202020-12-31−$13.9M

Cardiol Therapeutics net debt trends

Over the last five fiscal years, Cardiol Therapeutics's net debt decreased from −$13.9M to −$21.3M, a change of −$7.4M. The latest reported quarter, Q2 2026, shows −$26.0M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cardiol Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about CRDL yet. Start the conversation.

Write the first post